Global Health Innovative Technology (GHIT) Fund

About Global Health Innovative Technology (GHIT) Fund

The GHIT Fund (Global Health Innovative Technology Fund) is a Japan-based international public-private partnership fund dedicated to global health R&D. It mobilizes Japanese industry, academia, and research institutes to develop new drugs, vaccines, and diagnostics for malaria, tuberculosis, and neglected tropical diseases in collaboration with global partners.

Products & Services

Drugs, Vaccines, and Diagnostics:Development of innovative medical solutions targeting malaria, tuberculosis, and neglected tropical diseases through various R&D platforms.

R&D Platforms:Includes Target Research Platform, Screening Platform, Hit-to-Lead Platform, and Product Development Platform to support the creation of health technologies.

Specialties

Global Health R&D Drug Development Vaccine Development Diagnostics Malaria Research Tuberculosis Research Neglected Tropical Diseases

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: R&D Investment T: - FT: R&D Investment	A: 8800000 MR: - FA: USD 8.8 million FAN: 8800000	D: 2026-02-02 FD: 2026-02-02	5 investors
2	RT: Investment T: - FT: Investment	A: 460000 MR: - FA: approximately USD 460,000 FAN: 460000	D: 2025-12-07 FD: 2025-12-07	1 investors
3	RT: R&D Investment T: - FT: R&D Investment	A: 11600000 MR: - FA: USD 11.6 million FAN: 11600000	D: 2025-10-28 FD: 2025-10-28	5 investors
4	RT: Investment T: - FT: Investment	A: 7300000 MR: - FA: approximately USD 7.3 million FAN: 7300000	D: 2025-07-16 FD: 2025-07-16	5 investors
5	RT: Investment T: - FT: Investment	A: 11400000 MR: - FA: approximately USD 11.4 million FAN: 11400000	D: 2025-03-17 FD: 2025-03-17	1 investors
6	RT: Investment T: - FT: Investment	A: 12700000 MR: - FA: USD 12.7 million FAN: 12700000	D: 2025-01-29 FD: 2025-01-29	1 investors
7	RT: Investment T: - FT: Investment	A: 4000000 MR: - FA: USD 4.0 million FAN: 4000000	D: 2024-11-06 FD: 2024-11-06	5 investors
8	RT: Investment T: - FT: Investment	A: 10800000 MR: - FA: USD 10.8 million FAN: 10800000	D: 2024-05-08 FD: 2024-05-08	1 investors
9	RT: R&D Investment T: - FT: R&D Investment	A: 10800000 MR: - FA: USD 10.8 million FAN: 10800000	D: 2024-05-08 FD: 2024-05-08	6 investors
10	RT: Venture Capital T: - FT: Venture Capital	A: 8800000 MR: - FA: approximately USD 8.8 million FAN: 8800000	D: 2023-12-13 FD: 2023-12-13	1 investors
11	RT: Investment T: - FT: Investment	A: 8000000 MR: - FA: Approximately US$8.0 million FAN: 8000000	D: 2023-09-27 FD: 2023-09-27	1 investors
12	RT: Pledge T: - FT: Pledge	A: 24000000 MR: - FA: 24 million FAN: 24000000	D: 2023-05-10 FD: 2023-05-10	1 investors
13	RT: Investment T: - FT: Investment	A: 2900000 MR: - FA: approximately 400 million yen (US$2.9 million) FAN: 2900000	D: 2023-03-30 FD: 2023-03-30	5 investors
14	RT: Investment T: - FT: Investment	A: 1900000 MR: - FA: approximately 260 million yen FAN: 1900000	D: 2023-03-13 FD: 2023-03-13	1 investors

R&D Investment Latest

2026-02-02

$8.8M

5 investors (Pro only)

Investment 2025-12-07

$460K

R&D Investment 2025-10-28

$11.6M

View 13 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Tachi Yamada

Doctor

B

BT Slingsby

Founding CEO

O

Osamu Kunii

CEO, GHIT Fund

H

Hiroki Nakatani

Chair & Representative Director

K

Keiko Haga

COO

E

Eriko Mugitani

Director, Brand Communications

View 39 more team members with Pro

Unlock Full Team Directory

Recent News